StockData

iTonic vs Nexalin Technology

ITOC and NXL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ITOC and NXL compare

Nexalin Technology grew revenue faster over the last twelve months (24.2% versus 16.7% for iTonic).

iTonic keeps more of each dollar of sales as profit, with a net margin of −975% compared with −4139% at Nexalin Technology.

Nexalin Technology scores higher on the StockData Score (7 against 6 for iTonic), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricITOCNXL
Size and price
Market cap–$33.1M
Share price$1.96$1.50
Change, 1 year−79.6%−95.4%
Beta (5Y)1.262.79
Employees428
StockData Score
Total score67 (better)
Valuation score00
Growth score12 (better)
Performance score00
Health score55
Dividend score00
Valuation
P/S–152×
P/B–21.8×
Growth
Revenue growth (TTM)16.7%24.2% (better)
Profitability
Gross margin62.6%86.2% (better)
Operating margin−992% (better)−4203%
Net margin−975% (better)−4139%
FCF margin−619%–
Return on equity−36.0% (better)−240%
Return on invested capital−35.8% (better)−2105%
Financial health
Debt / equity0.000.00
Current ratio17.39 (better)1.25
Altman Z-score–−41.74
Piotroski F-score25 (better)
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions–0.13%
Held by insiders45.2%22.3%
Short interest, % of float0.04%0.07%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.